Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Wada

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Plos One|September 16, 2016
Development of Accelerated Coronary Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-Out Swine with Balloon InjuryManabu Ogita, Katsumi Miyauchi, Akira Onishi, et al.
BMC Cardiovascular Disorders|January 15, 2021
Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fractionJun Shitara, Ryo Naito, Takatoshi Kasai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 22, 2017
Prognostic impact of nutritional status assessed by the Controlling Nutritional Status score in patients with stable coronary artery disease undergoing percutaneous coronary interventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
The American Journal of Cardiology|January 24, 2022
Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With StatinsDaigo Takahashi, Hideki Wada, Manabu Ogita, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2017
Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary InterventionSatoru Suwa, Manabu Ogita, Katsumi Miyauchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 29, 2019
Impact of Lipoprotein (a) Levels on Long-Term Outcomes in Patients With Coronary Artery Disease and Left Ventricular Systolic DysfunctionJun Shitara, Takatoshi Kasai, Hirokazu Konishi, et al.
International Heart Journal|September 6, 2019
Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary InterventionTakashi Shimizu, Satoru Suwa, Tomotaka Dohi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 22, 2017
Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary InterventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
Journal of the American Heart Association|July 14, 2025
Left-Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention RegistryTakahiro Suzuki, Yuichiro Mori, John A Spertus, et al.
Journal of Cardiology|December 3, 2023
Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factorsYu Suresvar Singh, Hideki Wada, Manabu Ogita, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Plos One|September 16, 2016
Development of Accelerated Coronary Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-Out Swine with Balloon InjuryManabu Ogita, Katsumi Miyauchi, Akira Onishi, et al.
BMC Cardiovascular Disorders|January 15, 2021
Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fractionJun Shitara, Ryo Naito, Takatoshi Kasai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 22, 2017
Prognostic impact of nutritional status assessed by the Controlling Nutritional Status score in patients with stable coronary artery disease undergoing percutaneous coronary interventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
The American Journal of Cardiology|January 24, 2022
Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With StatinsDaigo Takahashi, Hideki Wada, Manabu Ogita, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2017
Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary InterventionSatoru Suwa, Manabu Ogita, Katsumi Miyauchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 29, 2019
Impact of Lipoprotein (a) Levels on Long-Term Outcomes in Patients With Coronary Artery Disease and Left Ventricular Systolic DysfunctionJun Shitara, Takatoshi Kasai, Hirokazu Konishi, et al.
International Heart Journal|September 6, 2019
Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary InterventionTakashi Shimizu, Satoru Suwa, Tomotaka Dohi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 22, 2017
Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary InterventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
Journal of the American Heart Association|July 14, 2025
Left-Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention RegistryTakahiro Suzuki, Yuichiro Mori, John A Spertus, et al.
Journal of Cardiology|December 3, 2023
Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factorsYu Suresvar Singh, Hideki Wada, Manabu Ogita, et al.
Pageof 9